Solid Biosciences Inc
SLDB
NASDAQ
Biotechnology
$9.20
USD
+0.12 (+1.32%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $976.82M
Volume 759.0K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SLDB | Solid Biosciences Inc | $976.82M | - | - | - | |
KURA | Kura Oncology Inc | $915.26M | - | - | - | |
DSGN | Design Therapeutics Inc | $900.55M | - | - | - | |
CADL | Candel Therapeutics Inc | $864.59M | - | - | - | |
ANNX | Annexon Inc | $856.08M | - | - | - | |
CLYM | Climb Bio Inc | $846.04M | - | - | - | |
AURA | Aura Biosciences Inc | $793.34M | - | - | - | |
CTMX | CytomX Therapeutics Inc | $738.68M | - | -87.0% | - | |
MNPR | Monopar Therapeutics Inc | $737.90M | - | - | - |
Top Peer by Growth
Janux Therapeutics Inc
+5367.0% YoY Revenue
Best 1-Year Return
Climb Bio Inc
+793.8% Return